“…Aptamers are typically a kind of short single‐stranded oligonucleotide (DNA or RNA) sequences with a length of about 25–80 bases that mimic monoclonal antibodies and can be artificially synthesized via a selection process named systematic evolution of ligands by exponential enrichment (SELEX) in vitro (Ni et al., 2021). Although aptamers are commonly recognized as “chemical antibody” or “the fourth‐generation antibody,” compared to antibodies, they not only possess high binding affinity and specificity, but also demonstrate superiority of convenient generation, easy modification, good stability, low manufacturing cost, nontoxicity, little batch‐to‐batch differences, reversible folding features, nonimmunogenicity, and wide range of targets including small molecules, peptides, proteins, cells, and tissues (Ni et al., 2021; Zon, 2020). As a highly selective biological recognition element, aptamers have attracted considerable interest for constructing various types of aptasensors, displaying remarkable advantages related to high specificity and outstanding sensitivity, low cost, small consumption of reagents and samples, simplicity, and high‐throughput analysis (Cheng, Liu, et al., 2020; Yi et al., 2020; Zhang, Fan, et al., 2020).…”